<--- Back to Details
First PageDocument Content
Pharmaceutical industry / Pharmacology / Health / Clinical investigator / Food and Drug Administration / Clinical trial / Title 21 of the Code of Federal Regulations / Good Clinical Practice / Clinical research / Pharmaceutical sciences / Research
Pharmaceutical industry
Pharmacology
Health
Clinical investigator
Food and Drug Administration
Clinical trial
Title 21 of the Code of Federal Regulations
Good Clinical Practice
Clinical research
Pharmaceutical sciences
Research

SMG[removed]FDA STAFF MANUAL GUIDES, VOLUME IV – AGENCY PROGRAM DIRECTIVES COMPLIANCE ACTIVITIES MAINTAINING AND CONTROLLING PART 16 REGULATORY HEARING ADMINISTRATIVE RECORDS FOR INVESTIGATOR DISQUALIFICATION

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 52,58 KB

Share Document on Facebook

Similar Documents

Workshop: How to be a good Chief Investigator 18 October 2016 Bristol A free one day training event for newly funded Chief Investigators on randomised clinical trials. The workshop will include panel discussions, present

Workshop: How to be a good Chief Investigator 18 October 2016 Bristol A free one day training event for newly funded Chief Investigators on randomised clinical trials. The workshop will include panel discussions, present

DocID: 1rXgp - View Document

2016 Call for Proposals: ACVIM Foundation / Zoetis Partnership Research grant with direct clinical application Background: The ACVIM Foundation (ACVIMF) and Zoetis have partnered to grant up to $60,000 for a project that

2016 Call for Proposals: ACVIM Foundation / Zoetis Partnership Research grant with direct clinical application Background: The ACVIM Foundation (ACVIMF) and Zoetis have partnered to grant up to $60,000 for a project that

DocID: 1rthB - View Document

Food and Drug Administration, HHS  § 50.3 PART 50—PROTECTION OF HUMAN SUBJECTS

Food and Drug Administration, HHS § 50.3 PART 50—PROTECTION OF HUMAN SUBJECTS

DocID: 1rraL - View Document

Identifying Investigators

Identifying Investigators

DocID: 1rqU5 - View Document

Can Cancer Experts Accurately Forecast the Replication of Cancer Biology Experiments? Lead Investigator: Jonathan Kimmelman Co-investigators: Daniel Benjamin Funding Agency: Canadian Institutes of Health Research Term: F

Can Cancer Experts Accurately Forecast the Replication of Cancer Biology Experiments? Lead Investigator: Jonathan Kimmelman Co-investigators: Daniel Benjamin Funding Agency: Canadian Institutes of Health Research Term: F

DocID: 1rp2G - View Document